BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20833486)

  • 21. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
    Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Swiss registry for patients with cystic fibrosis: design, programming, implementation and first examples of use].
    Schöni-Affolter F; Oswald P; Wandt-Baumann C; Kriemler S; Schöni MH
    Schweiz Med Wochenschr; 2000 Sep; 130(39):1373-81. PubMed ID: 11059028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn screening for cystic fibrosis in Wisconsin: first application of population-based molecular genetics testing.
    Farrell PM; Aronson RA; Hoffman G; Laessig RH
    Wis Med J; 1994 Aug; 93(8):415-21. PubMed ID: 7975706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic fibrosis birth rates in Canada: a decreasing trend since the onset of genetic testing.
    Dupuis A; Hamilton D; Cole DE; Corey M
    J Pediatr; 2005 Sep; 147(3):312-5. PubMed ID: 16182667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data.
    Lai HJ; Cheng Y; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S57-63. PubMed ID: 16202784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic fibrosis newborn screening.
    Com G
    J Ark Med Soc; 2010 Mar; 106(9):210-2. PubMed ID: 20337169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newborn screening for cystic fibrosis offers an advantage over symptomatic diagnosis for the long term benefit of patients: the motion for.
    McKay K; Wilcken B
    Paediatr Respir Rev; 2008 Dec; 9(4):290-4. PubMed ID: 19026370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of sweat testing for older siblings of patients with cystic fibrosis identified by newborn screening.
    Munck A; Houssin E; Roussey M
    J Pediatr; 2009 Dec; 155(6):928-930.e1. PubMed ID: 19914431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening.
    Thauvin-Robinet C; Munck A; Huet F; Génin E; Bellis G; Gautier E; Audrézet MP; Férec C; Lalau G; Georges MD; Claustres M; Bienvenu T; Gérard B; Boisseau P; Cabet-Bey F; Feldmann D; Clavel C; Bieth E; Iron A; Simon-Bouy B; Costa C; Medina R; Leclerc J; Hubert D; Nové-Josserand R; Sermet-Gaudelus I; Rault G; Flori J; Leroy S; Wizla N; Bellon G; Haloun A; Perez-Martin S; d'Acremont G; Corvol H; Clément A; Houssin E; Binquet C; Bonithon-Kopp C; Alberti-Boulmé C; Morris MA; Faivre L; Goossens M; Roussey M; ; Girodon E
    J Med Genet; 2009 Nov; 46(11):752-8. PubMed ID: 19880712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystic fibrosis in neonates and infants.
    Minasian C; McCullagh A; Bush A
    Early Hum Dev; 2005 Dec; 81(12):997-1004. PubMed ID: 16278058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of neonatal screening for cystic fibrosis on reproduction, attitudes toward reproductive behaviour and genetic knowledge.
    Dankert-Roelse JE; Knol K; ten Kate LP
    Acta Univ Carol Med (Praha); 1990; 36(1-4):99-101. PubMed ID: 2130734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The Italian registry for cystic fibrosis: what has changed in the last decade].
    Viviani L; Padoan R; Giglio L; Bossi A
    Epidemiol Prev; 2003; 27(2):91-6. PubMed ID: 12848021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatricians' attitudes toward expanding newborn screening.
    Acharya K; Ackerman PD; Ross LF
    Pediatrics; 2005 Oct; 116(4):e476-84. PubMed ID: 16199673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis: paediatric aspects.
    Wallis C
    Br J Hosp Med; 1996 Mar 6-19; 55(5):241-7. PubMed ID: 8777514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.
    Lee DS; Rosenberg MA; Peterson A; Makholm L; Hoffman G; Laessig RH; Farrell PM
    J Pediatr; 2003 Jun; 142(6):617-23. PubMed ID: 12838188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Early diagnosis of cystic fibrosis: to screen or not to screen?].
    Dankert-Roelse JE
    Tijdschr Kindergeneeskd; 1990 Feb; 58(1):49-54. PubMed ID: 2315906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.
    Arch Intern Med; 1999 Jul; 159(14):1529-39. PubMed ID: 10421275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening.
    Stick SM; Brennan S; Murray C; Douglas T; von Ungern-Sternberg BS; Garratt LW; Gangell CL; De Klerk N; Linnane B; Ranganathan S; Robinson P; Robertson C; Sly PD;
    J Pediatr; 2009 Nov; 155(5):623-8.e1. PubMed ID: 19616787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.